MAPK/ERK通路
白花丹
p38丝裂原活化蛋白激酶
磷酸化
激酶
信号转导
化学
炎症
NF-κB
蛋白激酶A
细胞生物学
αBκ
丝裂原活化蛋白激酶
肿瘤坏死因子α
药理学
分子生物学
生物
生物化学
内分泌学
免疫学
遗传学
作者
Tingyu Wang,Fei-Hua Wu,Zhigui Jin,Zanjing Zhai,Yugang Wang,Bing Tu,Wei Yan,Tingting Tang
标识
DOI:10.1016/j.fct.2013.11.027
摘要
Plumbagin (PL) has been reported to exhibit anti-carcinogenic, anti-inflammatory and analgesic activities, but little is known about its mechanism. In this study, we investigated the anti-inflammatory property of PL and its mechanism of action. Although no significant cytotoxicity of PL was observed over the concentration range tested, PL (2.5–7.5 μM) significantly and dose-dependently suppressed the secretion of pro-inflammatory mediators and inhibited the expression of TNF-α, IL-1β, IL-6 and iNOS in LPS-stimulated RAW 264.7 cells. Furthermore, PL consistently suppressed the activity of iNOS in LPS-induced RAW 264.7 cells. To elucidate the mechanism underlying the anti-inflammatory activity of PL, we assessed the effects of PL on the MAPK pathway and the activity and expression of NF-κB. These experiments demonstrated that PL significantly reduced the luciferase activity of an NF-κB promoter reporter and p65 nuclear translocation. The LPS-induced phosphorylation of MAP kinases was also attenuated by PL; significant changes were observed in the levels of phosphorylated ERK1/2, JNK and p38 MAPK. Additionally, MAPK inhibitors confirmed the inhibitory effect of PL on the MAPK pathway. Taken together, these data suggest that PL exerts its anti-inflammatory effects by down-regulating the expression of pro-inflammatory mediators through inhibition of NF-κB and MAPK signaling in LPS-stimulated RAW 264.7 cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI